Skip to main content
. Author manuscript; available in PMC: 2012 Feb 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):181–189. doi: 10.1097/QAI.0b013e3182174a76

TABLE 2.

Comparison of Frequencies of KIR2DL2, KIR2DL3, and HLA-C Allotypes and Combinations of KIR-HLA-C Between Responders and Nonresponders

Responders (n = 39) Nonresponders (n = 37) Responders vs Nonresponders


Percent Representation Odds Ratio 95% Confidence Interval P
KIR alleles
2DL2/2DL2 20.5 27 0.70 0.24–2.02 0.594
2DL2/2DL3 53.8 43.2 1.53 0.62–3.79 0.370
2DL3/2DL3 25.6 29.7 0.82 0.30–2.23 0.799
HLA-C alleles
C1/C1 20.5 24.3 0.93 0.32–2.69 1.000
C1/C2 59 45.9 1.52 0.61–3.76 0.491
C2/C2 20.5 29.7 0.61 0.21–1.74 0.431
KIR-HLA combinations
2DL1+C2 76.9 75.7 1.07 0.372–3.09 1.000
2DL2+C1 56.4 56.8 0.99 0.40–2.44 1.000
2DL3+C1 71.8 51.4 2.41 0.93–6.23 0.098
2DS1+C2 12.8 5.4 2.57 0.47–14.18 0.432
2DS2+C1 53.8 45.9 1.37 0.56–3.38 0.646
2DL1+C2C2 20.5 29.7 0.61 0.21–1.74 0.431
2DL2+C1C1 7.7 16.2 0.43 0.10–1.87 0.303
2DL3+C1C1 25.6 21.6 1.25 0.43–3.62 0.790
2DS1+C2C2 5.1 2.7 1.95 0.17–22.4 1.000
2DS2+C1C1 7.7 13.5 0.53 0.12–2.41 0.475
2DL2/2DL2+C1C1 0 2.7 0.487
2DL2/2DL2+C2C2 12.8 8.1 1.67 0.37–7.53 0.712
2DL2/2DL2+C1C2 7.7 16.2 0.43 0.10–1.87 0.303
2DL3/2DL3+C1C1 12.8 8.1 1.67 0.37–7.53 0.712
2DL3/2DL3+C2C2 2.6 16.2 0.14 0.02–1.19 0.053
2DL3/2DL3+C1C2 10.3 5.4 2.00 0.34–11.64 0.675
2DL2/2DL3+C1C1 10.3 13.5 0.73 0.18–2.96 0.733
2DL2/2DL3+C2C2 5.1 5.4 0.95 0.13–7.09 1.000
2DL2/2DL3+C1C2 38.5 24.3 0.70 0.72–5.23 0.222

Bold P values indicate trends (0.05 < P < 0.1).